SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:uu-396131"
 

Sökning: onr:"swepub:oai:DiVA.org:uu-396131" > Parent and child pe...

Parent and child perception of quality of life in a randomized controlled peanut oral immunotherapy trial

Reier-Nilsen, Tonje (författare)
Oslo Univ Hosp, Div Pediat & Adolescent Med, Oslo, Norway;Univ Oslo, Inst Clin Med, Oslo, Norway
Carisen, Karin C. Lodrup (författare)
Oslo Univ Hosp, Div Pediat & Adolescent Med, Oslo, Norway;Univ Oslo, Inst Clin Med, Oslo, Norway
Micheisen, Merethe Melbye (författare)
Oslo Univ Hosp, Div Pediat & Adolescent Med, Oslo, Norway;Univ Oslo, Inst Clin Med, Oslo, Norway
visa fler...
Drottning, Sebastian (författare)
Oslo Univ Hosp, Div Pediat & Adolescent Med, Oslo, Norway
Carlsen, Kai-Hakon (författare)
Oslo Univ Hosp, Div Pediat & Adolescent Med, Oslo, Norway;Univ Oslo, Inst Clin Med, Oslo, Norway
Zhang, Chi (författare)
Univ Oslo, Inst Basic Med Sci, Fac Med, Dept Biostat, Oslo, Norway
Borres, Magnus P, 1956- (författare)
Uppsala universitet,Institutionen för kvinnors och barns hälsa,Thermofisher Sci, Uppsala, Sweden
Haland, Geir (författare)
Oslo Univ Hosp, Div Pediat & Adolescent Med, Oslo, Norway;Univ Oslo, Inst Clin Med, Oslo, Norway
visa färre...
 (creator_code:org_t)
2019-07-25
2019
Engelska.
Ingår i: Pediatric Allergy and Immunology. - : WILEY. - 0905-6157 .- 1399-3038. ; 30:6, s. 638-645
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background Improved quality of life (QoL) after oral immunotherapy (OIT) in peanut allergic children is often reported by their parents, while the child's perspective is less clear. Objective We aimed to explore whether 2 years of OIT improved QoL in children with peanut allergy and to identify factors influencing change in QoL. Methods In the open-labeled TAKE-AWAY peanut OIT trial including children with anaphylaxis to peanuts, 57 were randomized to OIT and 20 to observation. The Pediatric Quality of Life Inventory Version 4.0 was completed by parents and children at enrollment (Y-0), after 1 year (end of updosing; Y-1) and after 2 years (Y-2) of OIT. Minimally clinically important difference (MCID) is >= 5.3. Perceived treatment burden was recorded by visual analogue scales, including adverse events (AEs). An open food challenge (OFC) was performed at Y-2. Results At Y-2, 18 children had discontinued OIT and 2 of 39 OIT children refused OFC, while 35 of 37 were desensitized to 7500 mg peanut protein. From Y-0 to Y-2,Y- the mean change (95% confidence intervals) in QoL was 4.4 (0.5, 8.3) among child self-reports and twice as large among parental proxy reports (9.3 [4.3, 14.3]; both P < 0.0001), without significant improvement among the controls. The change in QoL was significantly different from the controls for the parental proxy reports only (P = 0.002). Neither treatment burden nor AEs significantly predicted changes in QoL. Conclusion Two years of OIT improved child-QoL as reported by parents, but not by the children, suggesting that parents may overestimate improvement in child-QoL by OIT.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Lungmedicin och allergi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Respiratory Medicine and Allergy (hsv//eng)

Nyckelord

child
desensitization
double-blind placebo-controlled food challenge
oral immunotherapy
peanut allergy
perceived treatment burden
quality of life
self- and proxy reports
visual analogue scale

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy